Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Eichhorst, B., Arriola, E., Cerri, E., Verdugo, M., Letschert, K., Mourgues, X., Boughan, S., Pena, G., Wittig, B., Selenko-Gebauer, N., Schuh, A. and Ysebaert, L. (2017). Venetoclax for chronic lymphocytic leukemia: baseline characteristics and safety data from pre-approval cohort programs in the EU. Oncol. Res. Treat., 40. S. 140 - 141. BASEL: KARGER. ISSN 2296-5262

Weihrauch, M. R., Richly, H., von Bergwelt-Baildon, M. S., Hacker, U., Shimabukuro-Vornhagen, A., Nokay, B., Tschaika, M., Schmidt, M., Wittig, B. and Scheulen, M. E. (2010). Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - safety results of a clinical phase I study. EJC Suppl., 8 (7). S. 24 - 25. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1359-6349

Weihrauch, M. R., von Bergwelt-Baildon, M. S., Hacker, U., Richly, H., Holtick, U., Tschaika, M., Schmidt, M., Wittig, B., Nokay, B. and Scheulen, M. E. (2010). Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - clinical efficacy and immunological results of a phase I study. EJC Suppl., 8 (7). S. 23 - 25. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1359-6349

This list was generated on Sun May 26 07:53:53 2024 CEST.